Broadway Wealth Solutions’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$653K Sell
2,468
-47
-2% -$12.4K 0.29% 31
2026
Q2
$639K Buy
2,515
+101
+4% +$23.5K 0.3% 28
2026
Q1
$590K Sell
2,414
-274
-10% -$63.8K 0.31% 27
2025
Q4
$556K Sell
2,688
-126
-4% -$24.9K 0.3% 29
2025
Q3
$522K Sell
2,814
-103
-4% -$17.6K 0.29% 29
2025
Q2
$446K Buy
2,917
+103
+4% +$15.8K 0.28% 33
2025
Q1
$467K Sell
2,814
-83
-3% -$13K 0.34% 27
2024
Q4
$419K Buy
+2,897
New +$449K 0.32% 32

Other funds holding JNJ

Broadway Wealth Solutions's JNJ Position: Q3 2026 in Review

Broadway Wealth Solutions reduced its Johnson & Johnson (JNJ) stake by 1.9% in Q3 2026, selling an estimated $12.4K and leaving 2,468 shares worth $653K. The position accounts for 0.29% of the portfolio, ranked #31.

Broadway Wealth Solutions first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 2,986 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Broadway Wealth Solutions held 2,468 shares of Johnson & Johnson worth $653K as of Q3 2026.
  • Broadway Wealth Solutions sold 47 Johnson & Johnson shares in Q3 2026, an estimated $12.4K.
  • Johnson & Johnson made up 0.29% of Broadway Wealth Solutions's portfolio in Q3 2026, its #31 holding.
  • Broadway Wealth Solutions first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 2,986 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Broadway Wealth Solutions's 13F filing for Q3 2026, filed 21 Oct 2026.